20
Chengda Pharmaceuticals Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is LEVOCARNITINE USP, with a corresponding US DMF Number 19142.
Remarkably, this DMF maintains an Active status since its submission on January 26, 2006, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 09, 2015, and payment made on August 28, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II